Induction of corticosteroid insensitivity in human PBMCS by microbial superantigens

Journal of Allergy and Clinical Immunology

Volumn 105, Issue 4, 2000, Pages 782-787

  Hauk, Pia J ^a   Hamid, Qutayba A ^c   Chrousos, George P ^d   Leung, Donald Y M ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Dexamethasone; Glucocorticoid receptor ; Glucocorticoid resistance; Human PBMCs; Inflammation; Superantigens

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; PHORBOL 13 ACETATE 12 MYRISTATE; STAPHYLOCOCCUS ENTEROTOXIN B; STAPHYLOCOCCUS TOXIN; SUPERANTIGEN;

ARTICLE; CELL STIMULATION; DRUG SENSITIVITY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOCYTOCHEMISTRY; MITOSIS INHIBITION; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034048372     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2000.105807     Document Type: Article

References (26)

1. 1. Kotzin BL, Leung DY, Kappler J, Marrack P. Superantigens and their potential role in human disease. Adv Immunol 1993;54:99-166.
2. 2. Choi Y, Lafferty JA, Clements JR, Todd JK, Gelfand EW, Kappler J, et al. Selective expansion of T cells expressing V beta 2 in toxic shock syndrome. J Exp Mod 1990;172:981-4.
3. 3. Abe J, Kotzin BL, Meissner C, Melish ME, Takahashi M, Fulton D, et al. Characterization of T cell repertoire changes in acute Kawasaki disease. J Exp Med 1991;177:791-6.
4. 4. Paliard X, West SG, Lafferty JA, Clements JR, Kappler JW, Marrack P, et al. Evidence for the effects of a superantigen in rheumatoid arthritis. Science 1991;253:325-9.
5. 5. Hauk PJ, Wenzel SE, Trumble AE, Szefler SJ, Leung DY. Increased T-cell receptor vβ8+ T cells in bronchoalveolar lavage fluid of subjects with poorly controlled asthma: a potential role for microbial superantigens. J Allergy Clin Immunol 1999;104:37-45.
6. 6. Neuber K, Loliger C, Kohler I, Ring J. Preferential expression of T-cell receptor V beta-chains in atopic eczema. Acta Derm Venereol 1996;76: 214-8.
7. 7. Strickland I, Hauk PJ, Tramble AE, Picker LJ, Leung DYM. Evidence for superantigen involvement in skin homing of T cells in atopic dermatitis. J Invest Dermatol 1999;112:249-53.
8. 8. Abeck D, Ruzicka T. Bacteria and atopic eczema. In: Ruzicka T, Ring J, Przybilla B, editors. Handbook of atopic eczema. Berlin: Springer; 1991. p 212-20.
9. 9. Ezepchuk YV, Leung DYM, Middleton MH, Bina P, Reiser R, Norris DA. Staphylococcal toxins and protein A differentially induce cytotoxicity and release of tumor necrosis factor-alpha from human keratinocytes. J Invest Dermatol 1996;107:603-9.
10. 10. Leung DYM, Travers JB, Giorno R, Norris DA, Skinner R, Aelion J, et al. Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis. J Clin Invest 1995;96:2106-12.
11. 11. Valdimarsson H, Baker BS, Jonsdottir I, Powles A, Fry L. Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens? Immunol Today 1995;16:145-9.
12. 12. Wachs GN, Maibach HI. Co-operative double-blind trial of an antibiotic/corticoid combination in impetiginized atopic dermatitis. Br J Dermatol 1976;95:323-8.
13. 13. Spann JD, Landwehr LP, Nimmagadda S, Surs W, Leung DYM, .Szefler SJ. Effects of glucocorticoids on lymphocyte activation in patients with steroid-sensitive and steroid-resistant asthma. J Allergy Clin Immunol 1996;98:1073-9.
14. 14. Corrigan CJ, Brown PH, Barnes NC, Tsai JJ, Frew AJ, Kay AB. Glucocorticoid resistance in chronic asthma: peripheral blood T lymphocyte activation and comparison of the T lymphocyte inhibitory effects of glucocorticoids and cyclosporin A. Am Rev Respir Dis 1991;144:1026-32.
15. 15. Corrigan CJ, Bungre JK, Assoufi B, Cooper AE, Seddon H, Kay AB. Glucocorticoid resistant asthma: T-lymphocyte steroid metabolism and sensitivity to glucocorticoids and immunosuppressive agents. Eur Respir J 1996;9:2077-86.
16. 16. Leung DYM, Hamid Q, Vottero A, Szefler SJ, Surs W, Minshall E, et al. Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor beta. J Exp Med 1997;186:1567-74.
17. 17. Bamherger CM, Bamberger AM, de Castro M, Chrousos GP. Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest 1995;95:2435-41.
18. 18. Oakley RH, Sar M, Cidlowski JA. The human glucocorticoid receptor beta isoform: expression, biochemical properties, and putative function. J BiolChem 1996;271:9550-9.
19. 19. de Castro M, Elliot S, Kino T, Bamberger C, Karl M, Webster E, et al. The non-ligand binding beta-isoform of the human glucocorticoid receptor (hGR beta): tissue levels, mechanism of action, and potential physiologic role. Mol Med 1996;2:597-607.
20. 20. Leung DYM, Martin RJ, Szefler SJ, Sher ER, Ying S, Kay AB, et al. Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma. J Exp Med 1995;181:33-40.
21. 21. Hamid Q, Barkans J, Meng Q, Ying S, Abrams JS, Kay AB, et al. Human eosinophils synthesize and secrete interleukin-6, in vitro. Blood 1992;80:1496-501.
22. 22. Oakley RH, Jewell CM, Yudt MR, Bofetiado DM, Cidlowski JA. The dominant negative activity of the human glucocorticoid receptor beta isoform: specificity and mechanisms of action. J Biol Chem 1999;274:27857-66.
23. 23. Nimmagadda SR, Szefler SJ, Spahn JD, Surs W, Leung DYM. Allergen exposure decreases glucocorticoid receptor binding affinity and steroid responsiveness in atopic asthmatics. Am J Respir Crit Care Med 1997;155:87-93.
24. 24. Takei S, Arora YK, Walker SM. Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens. J Clin Invest 1993;91:602-7.
25. 25. Kraft M, Cassell GH, Bettinger CM, Duffy LB, Pak J, Martin RJ. Mycoplasma pneumoniae as a cofactor in chronic asthma [abstract]. Am Respir J Crit Care Med 1991;155:A65.
26. 26. Mazer BD, Gelfand EW. An open-label study of high-dose intravenous immunoglobulin in severe childhood asthma. J Allergy Clin Immunol 1991;87:976-83.